Sato H, Kuriyama-Matsumura K, Hashimoto T, Sasaki H, Wang H, Ishii T, et al
Apr 2009;12(2):334-9
If youre currently using a compounded GLP-1: Dont panic, but dont delay either Talk to your healthcare provider about transitioning to FDA-approved options If your current provider cant help, consider exploring telehealth services that offer weight loss support Check if your insurance covers FDA-approved GLP-1s (many do now) Look into manufacturer savings programs, which can significantly reduce costs Be prepared to start at a lower dose of the FDA-approved version and titrate up as directed Be proactive, Gardner advises
The pathophysiology of MASLD/MASH encompasses complex interactions among genetic background, impaired insulin signaling, hepatic lipid accumulation, inflammatory cascades, and progressive fibrosis
There have been concerns that GLP-1RAs may increase the risk of intestinal obstruction
Histological clarification by staged sections and confirmation of the precise tumor stage (pTis = melanoma in situ, Clark level I) is mandatory
